|
⚲
|
| Keyboard |
| Shrimpton Sean
✚
|
|
|---|---|
| CIK # | 0001706711 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001706711] | |
| 4 | [0001706711] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Abbott Laboratories | |
| Shrimpton Sean |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Abbott Laboratories ABT
Common shares without par value
|
2018-12-31 | Tax withheld | 481 | $71.09 | 34,194 |
|
Abbott Laboratories ABT
Common shares without par value
|
2018-05-15 | Tax withheld | 811 | $62.02 | 50,298 |
|
Abbott Laboratories ABT
Common shares without par value
|
2018-05-15 | Grant | 1,801 | $0.00 | |
|
Abbott Laboratories ABT
Common shares without par value
|
2018-02-19 | Tax withheld | 1,075 | $60.17 | 64,683 |
|
Abbott Laboratories ABT
Common shares without par value
|
2018-02-17 | Tax withheld | 1,423 | $60.17 | 85,622 |
|
Abbott Laboratories ABT
Option (right to buy) · derivative
|
2018-02-16 | Grant | 110,146 | $0.00 | |
|
Abbott Laboratories ABT
Common shares without par value
|
2017-12-31 | Tax withheld | 502 | $57.07 | 28,649 |
|
Abbott Laboratories ABT
Option (right to buy) · derivative
|
2017-05-15 | Grant | 92,032 | $0.00 |